{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T14:46:41Z","timestamp":1648910801666},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,28]],"date-time":"2011-12-28T00:00:00Z","timestamp":1325030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s13730-011-0001-2","type":"journal-article","created":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T11:39:40Z","timestamp":1324985980000},"page":"1-3","source":"Crossref","is-referenced-by-count":0,"title":["Anaphylactoid reaction to immunoadsorptive membrane in a patient with myasthenia gravis"],"prefix":"10.1007","volume":"1","author":[{"given":"Yoshihiko","family":"Kanno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugaku","family":"Date","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matsuhiko","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,28]]},"reference":[{"key":"1_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11584740-000000000-00000","volume":"31","author":"C Angelini","year":"2011","unstructured":"Angelini C. Diagnosis and management of autoimmune myasthenia gravis. Clin Drug Investig. 2011;31:1\u201314.","journal-title":"Clin Drug Investig"},{"key":"1_CR2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1196\/annals.1254.071","volume":"998","author":"L Psaridi-Linardaki","year":"2003","unstructured":"Psaridi-Linardaki L, Mamalaki A, Tzartos SJ. Future therapeutic strategies in autoimmune myasthenia gravis. Ann N Y Acad Sci. 2003;998:539\u201348.","journal-title":"Ann N Y Acad Sci"},{"key":"1_CR3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","volume":"76","author":"I Cortese","year":"2011","unstructured":"Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011;76:294\u2013300.","journal-title":"Neurology"},{"key":"1_CR4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.64.8.1121","volume":"64","author":"S Suzuki","year":"2007","unstructured":"Suzuki S, Utsugisawa K, Nagane Y, Satoh T, Terayama Y, Suzuki N, et al. Classification of myasthenia gravis based on autoantibody status. Arch Neurol. 2007;64:1121\u20134.","journal-title":"Arch Neurol"},{"key":"1_CR5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1212\/WNL.45.2.338","volume":"45","author":"D Grob","year":"1995","unstructured":"Grob D, Simpson D, Mitsumoto H, Hoch B, Mokhtarian F, Bender A, et al. Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology. 1995;45:338\u201344.","journal-title":"Neurology"},{"key":"1_CR6","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1212\/WNL.46.6.1644","volume":"46","author":"N Yuki","year":"1996","unstructured":"Yuki N. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher\u2019s syndrome: a new approach to treatment. Neurology. 1996;46:1644\u201351.","journal-title":"Neurology"},{"key":"1_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/14740330902778180","volume":"8","author":"TE Warkentin","year":"2009","unstructured":"Warkentin TE, Greinacher A. Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes. Expert Opin Drug Saf. 2009;8:129\u201344.","journal-title":"Expert Opin Drug Saf"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1046\/j.1365-2133.2003.05513.x","volume":"149","author":"M Luftl","year":"2003","unstructured":"Luftl M, Stauber A, Mainka A, Klingel R, Schuler G, Hertl M. Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber. Br J Dermatol. 2003;149:598\u2013605.","journal-title":"Br J Dermatol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-011-0001-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-011-0001-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-011-0001-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T16:44:55Z","timestamp":1559493895000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-011-0001-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,28]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1007\/s13730-011-0001-2","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,28]]}}}